Press Room

Press Clipping / May 11, 2020

Hovione helping out HSE and community groups with donations of hand sanitiser

Echo Live, May 11, 2020

A PHARMACEUTICAL company has donated hand sanitiser to the HSE as well as local organisations to help the fight against Covid-19.

Douglas GAA, camogie and ladies football clubs recently received a large donation of hand sanitiser for those that are helping out in their community during the pandemic.

Hovione is a contract pharmaceutical manufacturing company which helps bring new and off-patent drugs to market. 

Hovione, based in Ringaskiddy, has been manufacturing in Cork for 11 years and has more than  60 years experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates.

Hovione employs more than 200 people in Cork and approximately 1,800 globally including Lisbon and Loures in Portugal; Macau in China and New Jersey in America.

Hovione initially began manufacturing hand sanitiser for the protection of team members on site with dispensers placed across the site. 

Since then the demand for hand sanitiser grew in our external community. This lead Hovione to appoint a project team to bring the manufacturing of hand sanitiser to distribution, so that it was readily available for donation to help protect various facilities and institutions across Ireland.

Key dates: April 11 – first day of Manufacturing - 17 days after the project kicked off.

April 20  – First batch of hand sanitiser was collected for use at St Stephen’s Hospital, Glanmire.

A spokesperson for the companys said: "A special thanks to the Hovione’s Project team, Site Leadership Team, Manufacturing and Warehouse Teams for all they have done to help with this fight against Covid-19. 

"A heartfelt thank you from all at Hovione must be given to the various suppliers who have helped us fight Covid-19 together - SciChem Laboratory Supplies, OCON Chemicals Ltd, Carbon Group, Quitmann O’Neill Packaging Ltd, Schuetz Packaging and South Coast Sales.

"To date Hovione have supplied 17,000 litres across Ireland to nursing homes, care facilities, charities and hospitals. Hovione are working closely with An Garda Síochána to safely distribute hand sanitiser to the HSE across Ireland with 11,000 litres of hand sanitiser  collected from site recently.

"On an international scale Hovione are distributing hand sanitiser free across all of our sites to support the local communities of each country we manufacture in."

Chairman of Douglas GAA Club, Aidan O'Connor thanks Hovione for their generous donation to the various clubs.

 

Read the article published at EchoLive.ie








Hovione helping out HSE and community groups with donations of hand sanitiser | Hovione
Rory Noonan, second left, receiving a donation of hand sanitiser from Hovione Éireann to Douglas GAA, Camogie and Ladies Football Clubs for members who are helping out in their local community. Representing Hovione Éireann were: Conor Crosbie, project manager; Willie Walsh, warehouse operator and Michelle McEvoy, analytical chemist. Picture: Barry O’Donoghue









 

Also in the Press Room

See All

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026